Malaria, Cerebral

Also known as: Cerebral Malaria / Plasmodium falciparum malaria with cerebral complications / Cerebral malaria (disorder)

Drug	Drug Name	Drug Description
DB09274	Artesunate	Artesunate is an artemesinin derivative indicated for the initial treatment of severe malaria.

Drug	Drug Name	Target	Type
DB09274	Artesunate	Malaria protein EXP-1	target
DB09274	Artesunate	Cytochrome P450 2A6	enzyme
DB09274	Artesunate	UDP-glucuronosyltransferase 2B7	enzyme
DB09274	Artesunate	UDP-glucuronosyltransferase 1-9	enzyme
DB09274	Artesunate	ATP-binding cassette sub-family G member 2	transporter
DB09274	Artesunate	P-glycoprotein 1	transporter
DB09274	Artesunate	Solute carrier organic anion transporter family member 1B1	transporter
DB09274	Artesunate	Solute carrier family 22 member 8	transporter
DB09274	Artesunate	Serum albumin	carrier

Drug	Drug Name	Phase	Status	Count
DB09274	Artesunate	1	Completed	2
DB00742	Mannitol	1	Completed	1
DB17537	6-diazo-5-oxo-L-norleucine	1 / 2	Recruiting	1
DB01202	Levetiracetam	1 / 2	Completed	1
DB01202	Levetiracetam	2	Completed	1
DB00435	Nitric Oxide	2	Completed	1
DB09152	Nitrogen	2	Completed	1
DB00016	Erythropoietin	2 / 3	Unknown Status	1
DB00742	Mannitol	3	Unknown Status	1
DB00468	Quinine	3	Unknown Status	1